Articles

Everyone take note(book)

David H. Murdock Research Institute partners with ArtusLabs for cross-disciplinary electronic lab notebook
Written byJeffrey Bouley
| 2 min read

RESEARCH TRIANGLE PARK, N.C.—ArtusLabs Inc. recently announced a partnership with the David H. Murdock Research Institute (DHMRI) "to enable groundbreaking research" at the North Carolina Research Campus (NCRC), with the partnership focusing on the implementation of ArtusLabs' Ensemble Electronic Lab Notebook (E2LN) platform.

DHMRI will use E2LN—a Web-deployed, third-generation ELN that blends high usability at the bench with collaboration technologies—to capture experimental data, results and decision support needs for each of its laboratories. This is expected to enhance the availability of data and documents for use for critical scientific decision making, as well as supporting the disaster recovery needs of DHMRI.

To continue reading this article, subscribe for FREE toDrug Discovery News Logo

Subscribe today to keep up to date with the latest advancements and discoveries in drug development achieved by scientists in pharma, biotech, non-profit, academic, clinical, and government labs.

Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

About the Author

Here are some related topics that may interest you:

Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Researcher examining a multiwell plate alongside cell culture dishes in a laboratory.
Explore how direct cell lysis can reduce sample preparation steps and support efficient gene expression analysis by RT-qPCR.
Abstract rainbow-colored beams of light spreading across a dark background.
Compare fluorochromes based on resolution, spillover, antigen expression, and other factors that can affect panel performance.
Illustration of multiple glowing blue and purple spherical cells against a dark blue background.
As researchers embrace more complex cellular models, high-content analysis brings new opportunities and challenges to drug discovery.